HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong
Recruiting · NCT07530198 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 1 | 2026-04-15 | NCT07530198 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immuno Cure 1 Limited | 1 |
| Immuno Cure Holding (HK) Limited | 1 |
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Chinese University of Hong Kong Phase 1 Clinical Trial Centre at Prince of Wales Hospital | Shatin | Hong Kong | 1 |